KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Scope & Guideline

Fostering excellence in physiological and pharmacological studies.

Introduction

Delve into the academic richness of KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1226-4512
PublisherKOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
Support Open AccessNo
CountrySouth Korea
TypeJournal
Convergefrom 1997 to 2024
AbbreviationKOREAN J PHYSIOL PHA / KOREAN J. PHYSIOL. PHARMACOL.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA

Aims and Scopes

The Korean Journal of Physiology & Pharmacology focuses on advancing the understanding of physiological and pharmacological mechanisms through innovative research and methodologies.
  1. Pharmacology and Drug Development:
    The journal extensively covers pharmacological studies, including drug discovery, development, and the mechanisms of action of various pharmacological agents.
  2. Physiological Mechanisms:
    Research on physiological processes, including cardiac, renal, and neural functions, is a core area, aiming to elucidate underlying mechanisms and their implications for health and disease.
  3. Disease Models and Therapeutics:
    The journal features studies utilizing various animal models to investigate disease mechanisms and potential therapeutic interventions, contributing to translational medicine.
  4. Molecular and Cellular Biology:
    Research involving molecular biology techniques, including gene expression studies, signaling pathways, and cellular responses, is prominent, highlighting the interplay between cellular mechanisms and pharmacological effects.
  5. Integrative and Systems Biology:
    The integration of physiological and pharmacological data at the systems level is a unique contribution of the journal, promoting a holistic understanding of biological functions.
Recent publications indicate a shift towards several trending and emerging themes that highlight the journal's adaptive focus on contemporary issues in physiology and pharmacology.
  1. Network Pharmacology and Systems Biology:
    There is a growing emphasis on network pharmacology approaches, reflecting an interest in understanding complex interactions within biological systems and drug actions.
  2. Mitochondrial and Metabolic Research:
    Emerging themes related to mitochondrial function and metabolic pathways are increasingly prevalent, indicating a focus on energy metabolism and its implications for various diseases.
  3. Neuropharmacology and Neuroinflammation:
    Research into neuropharmacological effects and the role of inflammation in neurological disorders is gaining traction, aligning with the rising global interest in brain health.
  4. Nano-Drug Delivery Systems:
    The exploration of novel drug delivery systems, particularly nano-formulations, reflects a trend towards improving therapeutic efficacy and reducing side effects.
  5. Chronic Disease Management and Therapeutics:
    There is a notable increase in studies addressing chronic diseases, including diabetes and cardiovascular disorders, emphasizing the need for innovative therapeutic strategies.

Declining or Waning

As the field evolves, certain areas of focus within the journal appear to be diminishing in prominence, reflecting changing research priorities and interests.
  1. Traditional Herbal Medicine:
    While previously a significant focus, research on traditional herbal medicines has decreased, possibly due to a shift towards more mechanistic and molecular studies.
  2. Basic Pharmacology without Clinical Relevance:
    Studies that focus solely on basic pharmacological principles without clear clinical implications or applications are becoming less common, as the journal increasingly emphasizes translational research.
  3. Lesser-Known Animal Models:
    Research employing less common animal models has waned, with a trend towards using more established models that provide clearer insights into human pathophysiology.

Similar Journals

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Unveiling the Complexities of Human Physiology
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0008-4212Frequency: 12 issues/year

Canadian Journal of Physiology and Pharmacology, published by Canadian Science Publishing, is a leading peer-reviewed journal dedicated to advancing knowledge in the fields of physiology and pharmacology. With an ISSN of 0008-4212 and an E-ISSN of 1205-7541, this journal has been at the forefront of biomedical research since its inception in 1964. The journal operates within a constrained access model, ensuring a selective dissemination of high-quality research, while maintaining its esteemed position in the Q3 quartile across multiple relevant categories such as Medicine, Pharmacology, and Physiology as of 2023. Researchers, professionals, and students alike will find the journal a valuable resource for emerging trends and comprehensive studies that shape contemporary science, as evidenced by its competitive Scopus rankings. The Canadian Journal of Physiology and Pharmacology is vital for fostering scholarly dialogue and innovation in the scientific community, encouraging contributions that promote a deeper understanding of physiological and pharmacological phenomena.

JOURNAL OF EXPERIMENTAL BIOLOGY

Advancing the Frontiers of Biological Discovery
Publisher: COMPANY BIOLOGISTS LTDISSN: 0022-0949Frequency: 24 issues/year

JOURNAL OF EXPERIMENTAL BIOLOGY, published by COMPANY BIOLOGISTS LTD, stands as a cornerstone in the fields of Animal Science, Aquatic Science, Ecology, Insect Science, and Physiology. With a rich history dating back to 1945, this esteemed journal has continually provided a platform for high-quality research, evidenced by its impressive Q1 rankings across multiple categories in the 2023 Journal Citation Reports. Located in the United Kingdom, it serves an international audience, offering critical insights and advancements in various biological sciences. As a non-open access journal, it provides rigorous peer-reviewed articles that contribute profoundly to our understanding of biological processes and their implications. With an extensive reach among researchers, practitioners, and academia, the JOURNAL OF EXPERIMENTAL BIOLOGY is not only a repository of knowledge but also a catalyst for ongoing research and innovation in experimental biology.

GENERAL PHYSIOLOGY AND BIOPHYSICS

Driving Research in Vital Scientific Disciplines
Publisher: AEPRESS SROISSN: 0231-5882Frequency: 4 issues/year

GENERAL PHYSIOLOGY AND BIOPHYSICS, published by AEPRESS SRO, is a pivotal journal in the fields of biophysics and physiology, dedicated to advancing knowledge and fostering research in these increasingly vital disciplines. Established in 1983 and set to converge in 2024, the journal provides a platform for scholarly articles that explore the intricate relationships between biological systems and physical principles. Its current category quartiles include Q3 in Biophysics and Q4 in Physiology, demonstrating a growing influence among researchers, with current Scopus ranks reflecting its commitment to quality and relevance. Despite not being an open-access publication, the journal remains a valuable resource for professionals and students aiming to stay informed on the latest discoveries and methodologies. By supporting interdisciplinary research and innovation, GENERAL PHYSIOLOGY AND BIOPHYSICS plays a crucial role in shaping the understanding of complex biological interactions and applications in medicine.

Current Molecular Pharmacology

Fostering Dialogue in the Evolving World of Pharmacology
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1874-4672Frequency: 7 issues/year

Current Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.

European Journal of Pharmacology

Exploring the frontiers of therapeutic applications and drug development.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

Physiological Reviews

Connecting Scholars with Cutting-Edge Physiological Insights
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0031-9333Frequency: 4 issues/year

Physiological Reviews is a prestigious journal published by the American Physiological Society, dedicated to advancing our understanding of physiology across various domains. With an impressive impact factor that places it in Q1 quartiles for medicine, molecular biology, and physiology as of 2023, this journal is recognized as a leading source of high-quality reviews and research analyses. The journal has been a vital resource for the scientific community since its inception in 1945, providing in-depth and comprehensive insights that are crucial for both scholars and practitioners in the field. Although not an open-access publication, it remains widely accessible through institutional subscriptions, ensuring that crucial research findings are disseminated efficiently. With Scopus rankings that place it in the top percentile across multiple categories, Physiological Reviews continues to be an essential platform for the latest advancements and discoveries in physiology, making it indispensable for researchers, professionals, and students alike.

JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY

Decoding the Evolutionary Threads of Biochemical Processes
Publisher: PLEIADES PUBLISHING INCISSN: 0022-0930Frequency: 6 issues/year

JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, published by PLEIADES PUBLISHING INC, is a pivotal periodical that delves into the intricate relationships between biochemical processes and evolutionary dynamics. With its ISSN 0022-0930 and E-ISSN 1608-3202, this journal serves as a comprehensive platform for researchers, professionals, and students dedicated to understanding the physiological adaptations and biochemical mechanisms influenced by evolutionary pressures. Although it is not an open access journal, it offers valuable insights across its historically significant coverage spanning from 1972 to 2017, making it an essential resource for those working in agricultural, biological, and molecular sciences. Despite its current Scopus rankings revealing limited visibility within its fields, the journal remains committed to fostering scholarly dialogue and advancing knowledge in the realm of evolutionary biochemistry, especially for those exploring the ecological, genetic, and integrative physiological aspects of life.

Biology-Basel

Fostering Collaboration in Cutting-edge Biological Discoveries
Publisher: MDPIISSN: Frequency: 12 issues/year

Biology-Basel is a premier, peer-reviewed open-access journal published by MDPI since 2012, situated in the heart of Switzerland. With an E-ISSN of 2079-7737, this journal serves as a vital platform for the dissemination of innovative research across the broad spectrum of Agricultural and Biological Sciences, Biochemistry, Genetics, Molecular Biology, and Immunology. Recognized for its rigorous editorial standards and impactful findings, it currently ranks Q1 in Agricultural and Biological Sciences and holds impressive positions in several categories according to the 2023 Scopus rankings. The journal’s open-access model ensures that high-quality research is freely available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Spanning from 2012 to 2024, Biology-Basel is committed to reflecting the latest advancements in biological sciences, making it an essential resource in the ever-evolving landscape of biological research.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Navigating the Landscape of Therapeutic Advancements
Publisher: SPRINGERISSN: 0028-1298Frequency: 12 issues/year

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Fostering Collaboration for Transformative Medical Insights
Publisher: WILEYISSN: 0305-1870Frequency: 12 issues/year

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.